WHO plan on fake medicines could signal retreat from IMPACT
This article was originally published in SRA
In a move that could herald a reduction in the World Health Organization's controversial involvement in the IMPACT anti-counterfeiting initiative, the body is to set up a new, member state-run mechanism to tackle the problem of substandard, falsified and counterfeit medicines1.
You may also be interested in...
Coronavirus Notebook: WHO’s Plan For Vaccine Manufacturing In Lower-Income Countries, UK Urged To Back IP Waiver
The UK’s independent vaccines committee has finalized its recommendations for the second phase of the COVID-19 vaccination program, and safety issues with several vaccines are still hitting the headlines.
Coronavirus Notebook: Vaccine Shortage Fears Heightened By Safety Scares, Italian Jab Enters Phase II/III
Russia’s Sputnik V vaccine gets the all-clear in India as the COVAX initiative hits the shortages speed bump. Also, two more antibody treatments are OKd for use in COVID-19 in the UK.
The French authorities believe that the “heterologous prime-boost” approach is justified in the case of people aged under 55 years who are due to receive their second dose of the AZ COVID-19 vaccine.